Bright Minds 6/13

Mizuho's Graig Suvannavejh joins BiotechTV for Analyst Thursdays

Apr 18

Bright Minds

Mizuho's Graig Suvannavejh joins BiotechTV for Analyst Thursdays

He discusses Intra-Cellular, Axsome, Adaptimmune, EyePoint, Insmed, Immunocore, Immatics, and Terns.

Pear VC's Eddie Eltoukhy describes investing in life sciences early at the seed and pre-seed stages

Apr 18

Bright Minds

Pear VC's Eddie Eltoukhy describes investing in life sciences early at the seed and pre-seed stages

Eddie Eltoukhy explains the unique role that seed investors have in helping entrepreneurs succeed, he lists some areas of science of...

Wedbush's Robert Driscoll joins BiotechTV for Analyst Thursdays

Apr 11

Bright Minds

Wedbush's Robert Driscoll joins BiotechTV for Analyst Thursdays

He discusses Vertex's acquisition of Alpine Immune Science, Bloomberg's reporting on Janux, and more.

TCGX's Chen Yu describes the benefits of being able to focus on public and privates during different stages of the biotech cycle

Apr 9

Bright Minds

TCGX's Chen Yu describes the benefits of being able to focus on public and privates during different stages of the biotech cycle

Dr. Yu describes how TCGX's structure and nimbleness has led to investments in number companies that have been acquired over the last year.

Nobel laureate Carolyn Bertozzi and Acepodia Co-Founder Sonny Hsiao on the science of antibody-cell conjugates

Apr 3

Bright Minds

Nobel laureate Carolyn Bertozzi and Acepodia Co-Founder Sonny Hsiao on the science of antibody-cell conjugates

Dr. Bertozzi and Dr. Hsiao describe how Acepodia is leveraging biorthogonal chemistry to conjugate antibodies to allogeneic γδ2 T cells.

BTIG's Thomas Shrader joins BiotechTV for Analyst Thursdays from San Francisco

Mar 28

Bright Minds

BTIG's Thomas Shrader joins BiotechTV for Analyst Thursdays from San Francisco

Thomas Shrader shares his thoughts on biotech and comments on companies he covers.

William Blair's Andy Hsieh returns to Analyst Thursdays to talk radiopharma buyouts, obesity and more

Mar 21

Bright Minds

William Blair's Andy Hsieh returns to Analyst Thursdays to talk radiopharma buyouts, obesity and more

Andy Hsieh gives his take on the radiopharmaceutical space, Viking’s obesity data, Pyxis Oncology, Cardiff Oncology, Fibrogen.

BMO's Evan Seigerman takes a deep dive into the obesity space ahead of an investor summit

Mar 19

Bright Minds

BMO's Evan Seigerman takes a deep dive into the obesity space ahead of an investor summit

Evan Seigerman breaks down which companies and technologies are at the forefront of the the GLP space.

Welcoming Ali Gorman as BiotechTV's new Philadelphia area contributor

Mar 18

Bright Minds

Welcoming Ali Gorman as BiotechTV's new Philadelphia area contributor

Ali Gorman will be covering biotech news and cool research in the greater Philadelphia area for BiotechTV.

William Blair's Matt Phipps returns to BiotechTV for Analyst Thursdays

Mar 14

Bright Minds

William Blair's Matt Phipps returns to BiotechTV for Analyst Thursdays

Matt Phipps covers Janux, NewAmsterdam, Jasper, Autolus, Incyte, Merus, and Amgen.

Wedbush's Laura Chico joins BiotechTV for Analyst Thursdays

Mar 7

Bright Minds

Wedbush's Laura Chico joins BiotechTV for Analyst Thursdays

Laura Chico gives her take on the state of biotech and discusses Denali, Praxis, Viridian, Apellis, PepGen, and Edgewise.

Cellarity's CEO on harnessing technology to better understand disease from a whole cell approach

Mar 5

Bright Minds

Cellarity's CEO on harnessing technology to better understand disease from a whole cell approach

Fabrice Chouraqui describes Cellarity's platform and how it is being put to use for indications such as sickle cell disease and MASH.

New Amsterdam Pharma is trying to revive the CETP class for cardiovascular disease

Mar 5

Bright Minds

New Amsterdam Pharma is trying to revive the CETP class for cardiovascular disease

CEO Michael Davidson describes how Obicetrapib, which was reacquired from Amgen, is designed to produce more LDL lowering than others.

Nuvalent's CEO on overcoming kinase resistance and selectivity for its precision oncology medicines

Mar 4

Bright Minds

Nuvalent's CEO on overcoming kinase resistance and selectivity for its precision oncology medicines

Jim Porter describes the chemistry that has led to early stage success against ALK and ROS1.

Black Diamond Therapeutics' CEO on the company's 'MasterKey' approach to precision oncology

Mar 4

Bright Minds

Black Diamond Therapeutics' CEO on the company's 'MasterKey' approach to precision oncology

Mark Valleca describes Black Diamond's 'MasterKey' approach to precision oncology that's aimed at solving many mutations at once.

Using NK cell therapies for autoimmune disease and cancer with Artiva's CEO

Mar 1

Bright Minds

Using NK cell therapies for autoimmune disease and cancer with Artiva's CEO

Fred Aslan describes how Artiva is harnessing the ability of NK cells to act as a modulator of antibody dependent cellular cytotoxicity.

Mathai Mammen on being back to company building at Fog Pharma

Feb 28

Bright Minds

Mathai Mammen on being back to company building at Fog Pharma

He describes how Fog is leveraging the way α-helices mediate interactions with other proteins to solve the undruggable problem.

5AM Ventures' Andy Schwab shares his take on biotech cycles and key themes of today

Feb 28

Bright Minds

5AM Ventures' Andy Schwab shares his take on biotech cycles and key themes of today

Andy Schwab describes founding 5AM in 2002 and discusses portfolio companies Radionetics, Latigo, TMRW, and Skye Bioscience.

Biocom California's CEO on this week's Global Partnering and Investor Conference in La Jolla

Feb 28

Bright Minds

Biocom California's CEO on this week's Global Partnering and Investor Conference in La Jolla

Joseph Panetta introduces the conference and we discuss the state of biotech in California's numerous biotech hubs.

Yaron Werber previews the 44th Annual TD Cowen Health Care Conference

Feb 26

Bright Minds

Yaron Werber previews the 44th Annual TD Cowen Health Care Conference

He discusses some of the key theme of the conference including obesity, IgG, ATTR cardiomyopathy, and more.

Follow BiotechTV

Sponsors

Sponsor Spotlight

Get in Touch

Advertise:

News coverage opportunities:

Contributors

Advertise@BiotechTV.com

MediaOppty@BiotechTV.com

Ali Gorman

Philadelphia Area

Brian Orelli

San Diego Area

General equiries and feedback:

BiotechTV U:

Info@BiotechTV.com

Universities@BiotechTV.com

Amy Brown

United Kingdom Area

Chris Garabedian

BioVenture VoiCes

Brad Loncar

Founder

Join our mail list

Disclosures & Policies